309 related articles for article (PubMed ID: 30160018)
1. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
[TBL] [Abstract][Full Text] [Related]
2. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
[TBL] [Abstract][Full Text] [Related]
3. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Analysis of Foxp3
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
Pathol Oncol Res; 2018 Jul; 24(3):497-505. PubMed ID: 28669079
[TBL] [Abstract][Full Text] [Related]
5. CD163
Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
[TBL] [Abstract][Full Text] [Related]
6. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
[TBL] [Abstract][Full Text] [Related]
7. Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions.
Yagyuu T; Hatakeyama K; Imada M; Kurihara M; Matsusue Y; Yamamoto K; Obayashi C; Kirita T
Oral Oncol; 2017 May; 68():36-43. PubMed ID: 28438290
[TBL] [Abstract][Full Text] [Related]
8. Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Greeshma LR; Joseph AP; Sivakumar TT; Raghavan Pillai V; Vijayakumar G
Sci Rep; 2023 Dec; 13(1):21698. PubMed ID: 38066025
[TBL] [Abstract][Full Text] [Related]
9. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications.
Wang S; Sun M; Gu C; Wang X; Chen D; Zhao E; Jiao X; Zheng J
Eur J Oral Sci; 2014 Jun; 122(3):202-9. PubMed ID: 24796206
[TBL] [Abstract][Full Text] [Related]
11. PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications.
Luchini C; Cros J; Pea A; Pilati C; Veronese N; Rusev B; Capelli P; Mafficini A; Nottegar A; Brosens LAA; Noë M; Offerhaus GJA; Chianchiano P; Riva G; Piccoli P; Parolini C; Malleo G; Lawlor RT; Corbo V; Sperandio N; Barbareschi M; Fassan M; Cheng L; Wood LD; Scarpa A
Hum Pathol; 2018 Nov; 81():157-165. PubMed ID: 30031096
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
[TBL] [Abstract][Full Text] [Related]
14. PD-1 blockade prevents the progression of oral carcinogenesis.
Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q
Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220
[TBL] [Abstract][Full Text] [Related]
15. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
Cocks M; Taheri D; Ball MW; Bezerra SM; Del Carmen Rodriguez M; Ricardo BFP; Bivalacqua TJ; Sharma RB; Meeker A; Chaux A; Burnett AL; Netto GJ
Hum Pathol; 2017 Jan; 59():55-61. PubMed ID: 27663086
[TBL] [Abstract][Full Text] [Related]
16. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.
Ye X; Zhang J; Lu R; Zhou G
Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032
[TBL] [Abstract][Full Text] [Related]
17. Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study.
Yagyuu T; Funayama N; Imada M; Kirita T
PLoS One; 2021; 16(4):e0250359. PubMed ID: 33861793
[TBL] [Abstract][Full Text] [Related]
18. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4
Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI
Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Menguy S; Prochazkova-Carlotti M; Beylot-Barry M; Saltel F; Vergier B; Merlio JP; Pham-Ledard A
Am J Surg Pathol; 2018 Mar; 42(3):326-334. PubMed ID: 29112015
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]